KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus enzalutamide (enza) for enza-resistant metastatic castration-resistant prostate cancer (mCRPC)

• R. McDermott,
• J.N. Graff,
• E.S. Antonarakis,
• C.J. Hoimes,
• S.T. Tagawa,
• C. Hwang,
• D. Kilari,
• A.J.T. Tije,
• A. Omlin,
• U.N. Vaishampayan,
• A. Elliott,
• H. Wu,
• J. Kim,
• C. Schloss,
• J.S. De Bono

Affiliations

R. McDermott

J.N. Graff

E.S. Antonarakis

C.J. Hoimes

S.T. Tagawa

C. Hwang

D. Kilari

A.J.T. Tije

A. Omlin

U.N. Vaishampayan

A. Elliott

H. Wu

J. Kim

C. Schloss

J.S. De Bono